The most well known GLP-1 medication is Ozempic, though in Australia it is only approved for the management of Type 2 ...

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients ...

Hua Medicine Announces 2024 Annual Results - HuaTangNing completed its first full year for reimbursement under the National Rei ...

The following is a summary of “Optimizing SGLT2 inhibitor and GLP-1 RA prescribing in high-risk patients with diabetes: a ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

In just a few years, GLP-1s have made quite the name for themselves. Originally prescribed to treat diabetes, these meds really entered the zeitgeist for their notable weight loss side effects.